A malaria drug which Donald Trump was condemned for hailing as a possible COVID-19 treatment can increase survival rates by up to 200 per cent, scientists say. Scientists found that, when ventilated patients with a severe version of COVID were given high doses of hydroxychloroquine with zinc, their survival rates could increase dramatically. 'New study shows: Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients. 'In France, they had a very good test. He had declared that he was taking hydroxychloroquine to prevent COVID infectionOn August 22, Trump continued to tout the benefits of hydroxychloroquine.

Source: Daily Mail June 10, 2021 04:50 UTC